Association of tumor necrosis factor gene polymorphisms with susceptibility to dilated cardiomyopathy in a Han Chinese population

DNA and Cell Biology

Volumn 29, Issue 10, 2010, Pages 625-628

  Liang, Wei Bo ^a   Lv, Mei Li ^a   Su, Xiao Wei ^a   Gao, Lin Bo ^a   Fang, Wen Liang ^a   Luo, Hai Bo ^a   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONFIDENCE INTERVAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957741264     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1044     Document Type: Article

References (22)

1. Balakrishnan, V. S., Guo, D., Rao, M., Jaber, B. L., Tighiouart, H., Freeman, R. L., Huang, C., King, A. J., and Pereira, B. J. (2004). Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65, 1449-1460.
2. Bristow, M. R. (1998). Tumor necrosis factor-alpha and cardiomyopathy. Circulation 97, 1340-1341.
3. Bruggink, A. H., van Oosterhout, M. F., De Jonge, N., Gmelig-Meyling, F. H., and De Weger, R. A. (2008). TNFalphain patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device. Transpl Immunol 19, 64-68.
4. Castardeli, E., Duarte, D. R., Minicucci, M. F., Azevedo, P. S., Matsubara, B. B., Matsubara, L. S., Campana, A. O., Paiva, S. A., and Zornoff, L. A. (2007). Tobacco smoke-induced left ventricular remodelling is not associated with metalloproteinase-2 or-9 activation. Eur J Heart Fail 9, 1081-1085.
5. Dhingra, S., Sharma, A. K., Arora, R. C., Slezak, J., and Singal, P. K. (2009). IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis. Cardiovasc Res 82, 59-66.
6. Dunlay, S. M., Weston, S. A., Redfield, M. M., Killian, J. M., and Roger, V. L. (2008). Tumor necrosis factor-alpha and mortality in heart failure: a community study. Circulation 118, 625-631.
7. Grimm, W., Christ, M., Bach, J., Muller, H. H., and Maisch, B. (2003). Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 108, 2883-2891.
8. Grunig, E., Tasman, J. A., Kucherer, H., Franz, W., Kubler, W., and Katus, H. A. (1998). Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31, 186-194. (Pubitemid 28064741)
9. Haren, M. T., Malmstrom, T. K., Miller, D. K., Patrick, P., Perry, H. M., 3rd, Herning, M. M., Banks, W. A., and Morley, J. E. (2010). Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans. J Gerontol A Biol Sci Med Sci 65, 274-281.
10. Jobe, L. J., Melendez, G. C., Levick, S. P., Du, Y., Brower, G. L., and Janicki, J. S. (2009). TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol 297, H1462-H1468.
11. Kamizono, S., Yamada, K., Seki, N., Higuchi, T., Kimura, A., Nonaka, K., and Itoh, K. (2000). Susceptible locus for obese type 2 diabetes mellitus in the 5'-flanking region of the tumor necrosis factor-alpha gene. Tissue Antigens 55, 449-452.
12. Kaur, K., Sharma, A. K., and Singal, P. K. (2006). Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291, H106-H113.
13. Kohaar, I., Tiwari, P., Kumar, R., Nasare, V., Thakur, N., Das, B. C., and Bharadwaj, M. (2009). Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 114, 347-355.
14. Monden, Y., Kubota, T., Inoue, T., Tsutsumi, T., Kawano, S., Ide, T., Tsutsui, H., and Sunagawa, K. (2007). Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Am J Physiol Heart Circ Physiol 293, H743-H753.
15. Park, K., Kim, N., Nam, J., Bang, D., and Lee, E. S. (2006). Association of TNFA promoter region haplotype in Behcet's disease. J Korean Med Sci 21, 596-601.
16. Sanchez, R., Levy, E., Costea, F., and Sinnett, D. (2009). IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J Gastroenterol 15, 3776-3782.
17. Satoh, M., Nakamura, M., Akatsu, T., Shimoda, Y., Segawa, I., and Hiramori, K. (2005). C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy. Eur J Heart Fail 7, 748-754.
18. Seidman, J. G., and Seidman, C. (2001). The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104, 557-567.
19. Ueland, T., Aukrust, P., Damas, J. K., Gullestad, L., and Yndestad, A. (2006). The tumor necrosis factor superfamily in heart failure. Future Cardiol 2, 101-111.
20. Um, J. Y., An, N. H., and Kim, H. M. (2003). TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 21, 167-171.
21. Yndestad, A., Damas, J. K., Oie, E., Ueland, T., Gullestad, L., and Aukrust, P. (2007). Role of inflammation in the progression of heart failure. Curr Cardiol Rep 9, 236-241.
22. Zimmermann, O., Kochs, M., Zwaka, T. P., Bienek-Ziolkowski, M., Hoher, M., Hombach, V., and Torzewski, J. (2007). Prognostic role of myocardial tumor necrosis factor-alpha and terminal complement complex expression in patients with dilated cardiomyopathy. Eur J Heart Fail 9, 51-54.